These innovative treatments, Retatrutide, represent a groundbreaking advancement in managing obesity and possibly associated conditions . They all are classified as GLP-1 pathway stimulators, meaning these substances to emulate the body's GLP-1 hormone , boosting insulin release and suppressing hunger . Despite Retatrutide each functions relatively